Resveratrol inhibits the proliferation of A549 cells by inhibiting the expression of COX-2

References

• GaoTZhouXLLiuSRaoCXShiWLiuJCIn vitro effects of nicotine on the non-small-cell lung cancer line A549J Pak Med Assoc201666436837227122258
   PubMed Web of Science ®Google Scholar
• ChiFWuRJinXJiangMZhuXHER2 induces cell proliferation and invasion of non-small-cell lung cancer by upregulating COX-2 expression via MEK/ERK signaling pathwayOnco Targets Ther201692709271627217781
   PubMed Web of Science ®Google Scholar
• RolfoCGiovannettiEHongDSNovel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitorsCancer Treat Rev2014408990100424953979
   PubMed Web of Science ®Google Scholar
• KlasterskyJAwadaAMilestones in the use of chemotherapy for the management of non-small cell lung cancer (NSCLC)Crit Rev Oncol Hematol2012811495721396829
   PubMed Web of Science ®Google Scholar
• BottMJPatelAPCrabtreeTDRole for surgical resection in the multidisciplinary treatment of stage IIIB non-small cell lung cancer (NSCLC)Ann Thorac Surg20159961921192825912748
   PubMed Web of Science ®Google Scholar
• BunnPAEarly-stage NSCLC: the role of radiotherapy and systemic therapyJ Natl Compr Canc Netw20042Suppl 2S31S4019780244
   PubMedGoogle Scholar
• LanghammerSRationale for the design of an oncology trial using a generic targeted therapy multi-drug regimen for NSCLC patients without treatment options (Review)Oncol Rep20133041535154123877481
   PubMed Web of Science ®Google Scholar
• JingXChengWWangSLiPHeLResveratrol induces cell cycle arrest in human gastric cancer MGC803 cells via the PTEN-regulated PI3K/Akt signaling pathwayOncol Rep201635147247826530632
   PubMed Web of Science ®Google Scholar
• PiotrowskaHKucinskaMMuriasMBiological activity of piceatannol: leaving the shadow of resveratrolMutat Res20127501608222108298
   PubMed Web of Science ®Google Scholar
• KucinskaMPiotrowskaHLuczakMWEffects of hydroxylated resveratrol analogs on oxidative stress and cancer cells death in human acute T cell leukemia cell line: prooxidative potential of hydroxylated resveratrol analogsChem Biol Interact20142099611024398169
   PubMed Web of Science ®Google Scholar
• AggarwalBBBhardwajAAggarwalRSSeeramNPShishodiaSTakadaYRole of resveratrol in prevention and therapy of cancer: preclinical and clinical studiesAnticancer Res2004245A2783284015517885
   PubMed Web of Science ®Google Scholar
• SinhaDSarkarNBiswasJBishayeeAResveratrol for breast cancer prevention and therapy: preclinical evidence and molecular mechanismsSemin Cancer Biol201640–41209232
   PubMed Web of Science ®Google Scholar
• CaoLChenXXiaoXMaQLiWResveratrol inhibits hyperglycemia-driven ROS-induced invasion and migration of pancreatic cancer cells via suppression of the ERK and p38 MAPK signaling pathwaysInt J Oncol201649273574327278736
   PubMed Web of Science ®Google Scholar
• YuanSXWangDXWuQXBMP9/p38 MAPK is essential for the antiproliferative effect of resveratrol on human colon cancerOncol Rep201635293994726555012
   PubMed Web of Science ®Google Scholar
• KirkbyNSChanMVZaissAKSystematic study of constitutive cyclooxygenase-2 expression: role of NF-κB and NFAT transcriptional pathwaysProc Natl Acad Sci U S A2016113243443926712011
   PubMed Web of Science ®Google Scholar
• GongWHZhaoNZhangZMZhangYXYanLLiJBThe inhibitory effect of resveratrol on COX-2 expression in human colorectal cancer: a promising therapeutic strategyEur Rev Med Pharmacol Sci20172151136114328338176
   PubMed Web of Science ®Google Scholar
• GülerSAUğurluMÜKayaHŞenSNazlıYGüllüoğluBMImpact of cyclooxygenase-2 over-expression on the prognosis of breast cancer patientsUlus Cerrahi Derg2015322818827436928
   PubMedGoogle Scholar
• MaLLiWWangRNanYWangQResveratrol enhanced anticancer effects of cisplatin on non-small cell lung cancer cell lines by inducing mitochondrial dysfunction and cell apoptosisInt J Oncol20154741460146826314326
   PubMed Web of Science ®Google Scholar
• WhynottRMManahanPGeislerJPVascular endothelial growth factor (VEGF) and cyclooxygenase 2 (COX 2) immunostaining in ovarian cancerEur J Gynaecol Oncol201637216416627172738
   PubMed Web of Science ®Google Scholar
• WhyteLHuangYYTorresKMehtaRGMolecular mechanisms of resveratrol action in lung cancer cells using dual protein and microarray analysesCancer Res20076724120071201718089832
   PubMed Web of Science ®Google Scholar
• YangQXuEDaiJA novel long noncoding RNA AK001796 acts as an oncogene and is involved in cell growth inhibition by resveratrol in lung cancerToxicol Appl Pharmacol20152852798825888808
   PubMed Web of Science ®Google Scholar
• NiePHuWZhangTYangYHouBZouZSynergistic induction of erlotinib-mediated apoptosis by resveratrol in human non-small-cell lung cancer cells by down-regulating survivin and up-regulating PUMACell Physiol Biochem20153562255227125895606
   PubMed Web of Science ®Google Scholar
• CastroMADal-PizzolFZdanovSCFL1 expression levels as a prognostic and drug resistance marker in non-small-cell lung cancerCancer2010116153645365520564088
   PubMed Web of Science ®Google Scholar
• WangTNelsonRABogardusAGrannisFWJrFive-year lung cancer survival: which advanced stage nonsmall cell lung cancer patients attain long-term survival?Cancer201011661518152520108308
   PubMed Web of Science ®Google Scholar
• FariaALAraújoASoaresMAzevedoIda SilvaJLRetrospective study about using topotecan in second-line treatment of small-cell lung cancer. Experience of a single institution, from 2002 to 2006J Thorac Oncol200728Suppl 4S825
   Google Scholar
• LiuCHChangSHNarkoKOverexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic miceJ Biol Chem200127621185631856911278747
   PubMed Web of Science ®Google Scholar
• HangJHuHHuangJSp1 and COX2 expression is positively correlated with a poor prognosis in pancreatic ductal adenocarcinomaOncotarget2016719282072821727057636
   PubMedGoogle Scholar
• XiaoYWangJQinYKu80 cooperates with CBP to promote COX-2 expression and tumor growthOncotarget20156108046806125797267
   PubMed Web of Science ®Google Scholar
• WangJXuanYGuoWDuGDengWAbstract 1019: hnRNPA2/B1 upregulates COX-2 expression and tumor growth and predicts poor prognosis in human lung cancersCancer Res201575151019
   Web of Science ®Google Scholar
• LinYMKuoWWVelmuruganBKHelioxanthin suppresses the cross talk of COX-2/PGE2 and EGFR/ERK pathway to inhibit Arecoline-induced Oral Cancer Cell (T28) proliferation and blocks tumor growth in xenografted nude miceEnviron Toxicol201631122045205626464283
   PubMed Web of Science ®Google Scholar
• LinkeBSchreiberYPicard-WillemsBActivated platelets induce an anti-inflammatory response of monocytes/macrophages through cross-regulation of PGE2 and cytokinesMediators Inflamm20172017146321628592915
   PubMed Web of Science ®Google Scholar
• WalleTHsiehFDeLeggeMHOatisJEWalleUKHigh absorption but very low bioavailability of oral resveratrol in humansDrug Metab Dispos200432121377138215333514
   PubMed Web of Science ®Google Scholar
• Davidov-PardoGMcClementsDJResveratrol encapsulation: designing delivery systems to overcome solubility, stability and bioavailability issuesTrends Food Sci Technol201438288103
   Web of Science ®Google Scholar
• NevesARMartinsSSegundoMAReisSNanoscale delivery of resveratrol towards enhancement of supplements and nutraceuticalsNutrients20168313126950147
   PubMed Web of Science ®Google Scholar